Month: June 2021

Market launch of LAST® brand Paris, 14 June 2021: Global Bioenergies today launches its LAST brand, the first range of longwear make-up with over 90% natural ingredients: the range’s 18 mascara, eyebrow mascara and eye shadow products can now be obtained on www.colors-that-last.com. Instrumental tests and clinical studies demonstrate performance on a par with the best conventional products on the market: this is the first time a brand with over 90% natural ingredients has delivered such a performance. The LAST range of products will be available for purchase from 2 p.m. on Monday 14 June 2021 on www.colors-that-last.com. Marc Delcourt, Chief Executive Officer of Global Bioenergies, explained: “This is a major step forward for us: Global Bioenergies had to reinvent itself to produce this range of ultra high-performance products of outstanding...

MARSEILLE, France, June 14, 2021 (GLOBE NEWSWIRE) — Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or “AMF”) General Regulation, Innate Pharma SA (the “Company” – Euronext Paris: FR0010331421 – IPH; Nasdaq: IPHA) releases its total number of shares outstanding as well as its voting rights as of June 1, 2021:Total number of shares outstanding: 79,027,540 ordinary shares     6,796 Preferred Shares 2016     7,581 Preferred Shares 2017   Total number of theoretical voting rights (1): 79,822,040   Total number of exercisable voting rights (2): 79,803,465(1) The total number of theoretical voting rights (or “gross” voting rights) is used as the basis for calculating the crossing of...

Marseille, France, June 14, 2021 (GLOBE NEWSWIRE) — Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or “AMF”) General Regulation, Innate Pharma SA (the “Company” – Euronext Paris: FR0010331421 – IPH; Nasdaq: IPHA) releases its total number of shares outstanding as well as its voting rights as of June 1, 2021:  Total number of shares outstanding: 79,027,540 ordinary shares  6,796 Preferred Shares 2016 7,581 Preferred Shares 2017Total number of theoretical voting rights (1): Total number of exercisable voting rights (2): 79,822,040 79,803,465  (1) The total number of theoretical voting rights (or “gross” voting rights) is used as the basis for calculating the crossing of shareholding thresholds....

VANCOUVER, British Columbia and IRVINE, Calif., June 14, 2021 (GLOBE NEWSWIRE) — PowerTap Hydrogen Capital Corp. (NEO: MOVE)(FWB: 2K6)(OTC: MOTNF) (“PowerTap” or the “Company” or “MOVE”) is pleased to announce that, further to its announcement on June 7, 2021, the Company has completed its name change to “PowerTap Hydrogen Capital Corp.”, effective as of the date hereof. This name change is in conjunction with the Company’s transition to a single purpose hydrogen fueling technology company, previously announced on June 1, 2021. Financial results will be reported on a consolidated basis for the period commencing June 1, 2021. The Company will continue to trade under the stock symbols “MOVE” on the NEO Exchange (“NEO”), “MOTNF” on the OTC Markets, and “2K6”...

FOSTER CITY, Calif., June 13, 2021 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and other chronic liver diseases, announced that the Company will host a conference call and live webcast on Monday, June 14, 2021 at 8:30 a.m. ET (5:30 a.m. PT) to discuss new top-line data from the Phase 2a LIFT study evaluating TERN-101 in patients with NASH. Webcast and conference call details are as follows: Webcast link: https://edge.media-server.com/mmc/p/2gsxxmta Live Conference CallDomestic Callers (U.S./Canada toll-free): (833) 665-0612International Callers: (929) 517-0403Conference ID: 7587739 Following the...

VANCOUVER, British Columbia, June 13, 2021 (GLOBE NEWSWIRE) — Finning International Inc. (TSX: FTT) (“Finning”, “the Company”, “we”, “our” or “us”) is hosting a virtual Investor Day on June 14 starting at 11:00 AM Eastern Time. Following the presentations by members of our leadership team, participants will have an opportunity to ask questions using the webcast portal. “We continue to execute on our Global Strategic Priorities designed to improve our return on invested capital performance and ultimately increase our earnings capacity. Robust execution through 2020 put us back on track to achieve strong ROIC in line with our 2018 investor day objectives, albeit one year later. Significant ROIC improvements in all three regions will be increasingly evident starting with our Q2 2021 results, as improved market activity that we had...

SOUTH SAN FRANCISCO, Calif., June 13, 2021 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today announced that the Company plans to report top line data from its Phase 1b clinical trial of RPT193 in patients with moderate to severe atopic dermatitis (AD) in a premarket press release and webcast on Monday, June 14, 2021. RAPT will host a conference call accompanied by a slide presentation at 8:30 a.m. ET on Monday, June 14th. The live webcast and audio archive of the presentation may be accessed on the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations. The call can...